Comprehensive collection of molecular diagnostic assays for cancer detection and analysis. Includes advanced testing solutions for lung cancer and other oncological applications.
Manufactured by
Taipei City, Taiwan
About PlexBio PlexBio Co., Ltd., founded in 2010 and headquartered in Taiwan, is a leading developer and manufacturer of multiplex in vitro diagnostic (IVD) solutions tailored for precision medicine. At the core of PlexBio s innovation is the patented πCode® MicroDisc technology, enabling simultaneous detection of dozens to hundreds of genetic mutations or biomarkers in a single reaction. This forms the basis of the IntelliPlex® platform , supporting applications in oncology, infectious diseases, and immunoassays. To streamline laboratory workflows, PlexBio developed the IntelliPrep TRIO 240 —a fully automated sample preparation system that integrates nucleic acid extraction, quantification, normalization, and PCR assay setup. Supporting up to 24 samples per run, TRIO 240 reduces hands-on time and minimizes human error, while ensuring standardized sample prep for downstream applications such as qPCR, dPCR, NGS, or PlexBio's πCode-based detection. PlexBio is committed to improving diagnostic accuracy, reducing testing costs, and enhancing patient outcomes by delivering innovative, scalable, and cost-effective molecular testing solutions. With ISO 13485, GMP, CE-IVD, and FDA-listed products, PlexBio continues to expand globally through clinical collaborations, RUO/LDT applications, and distribution partnerships.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Saygen Genetics
United Arab Emirates · 1 relevant product
Molecular Designs
United States · 1 relevant product
Roche Pharma
Switzerland · 2 relevant products
EPITOPE DIAGNOSTICS, INC.
United States · 2 relevant products
Medicover Genetics Ltd
Cyprus · 1 relevant product
BD
United States · 1 relevant product
Origin Biotechnology Co., Ltd.
Taiwan · 1 relevant product
Medix Biochemica Oy AB
Finland · 1 relevant product
DIANA Biotechnologies, a.s.
Czech Republic · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
59 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 89 closest product alternatives
Saygen Genetics · United Arab Emirates
Comprehensive portfolio of advanced molecular diagnostic assays supporting human healthcare applications. These assays integrate cutting-edge science with practical laboratory applications for enhanced accuracy and reliability.
Molecular Designs · United States
Portfolio of eight distinct research assay panels with customizable configurations designed to run on most PCR platforms. Panels are engineered to identify low-abundance targets and support cost-effective molecular research.
Roche Pharma · Switzerland
Comprehensive range of diagnostic products and services for disease prevention, detection, and monitoring across major therapeutic areas.
EPITOPE DIAGNOSTICS, INC. · United States
ECL100 tumor marker portfolio delivers electrochemiluminescence-based immunoassays for quantitative detection of cancer biomarkers. This ELISA kit system enables clinical laboratories to assess tumor markers for oncology screening, diagnosis, and patient monitoring. The assay provides sensitive, specific results with standardized protocols suitable for high-throughput diagnostic workflows.
Medicover Genetics Ltd · Cyprus
Comprehensive genetic testing portfolio for cancer, rare diseases, and reproductive health delivered through CE IVD-marked kits and technology transfer solutions. Enables healthcare professionals to identify appropriate genetic tests for patient diagnosis and risk stratification. Supported by clinical validation, genetic counselling, and CAP/GMP/ISO certifications for laboratory implementation.
BD · United States
Products and systems for cervical cancer detection and prevention screening programs. These diagnostic solutions support early detection and improved patient outcomes.
Origin Biotechnology Co., Ltd. · Taiwan
Molecular diagnostic tests for rapid and accurate detection of genetic diseases and maternal-fetal health conditions. Designed for screening and diagnosis of inherited disorders and prenatal care applications. Enables early disease prevention and clinical intervention through advanced molecular detection technology.
Medix Biochemica Oy AB · Finland
Comprehensive portfolio of over 5000 diagnostic raw materials for in vitro diagnostic assay development and validation globally.
DIANA Biotechnologies, a.s. · Czech Republic
Portfolio of PCR-based diagnostic kits for laboratory and clinical use. Supports disease identification across multiple therapeutic areas with high analytical sensitivity.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
Helio Diagnostics · France
Oncology-focused diagnostic assays including tumor markers and genetic testing solutions. Developed with clinical evidence, validated processes, and regulatory pathways established for market approval.
International Company for medical eq. · Egypt
Molecular diagnostic testing for cancer detection and monitoring.
77 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products